Geralt, "Balloon Thought Bubble Head Man" 15/08/31 via pixabay
Public Domain Dedication License
In my cluster, I touched on the motivations and weighing of the choices that the major players in the debate of direct-to-consumer advertising (DCTA) had. The pharmaceutical industry and consumer advocacy groups have a direct link to the controversy: The pharmaceutical industry reaches a wider audience by taking advantage of DCTA, while consumer advocacy fights on behalf of consumers of DCTA, ensuring that they are not misinformed by enterprising companies. They are not the sole players, however: the FDA acts on the behalf of consumers by regulating the pharmaceutical industry, yet it must juggle its own concerns on encouraging the lucrative DCTA business.
No comments:
Post a Comment